Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I find MedCity News a great resource for taking the pulse of the market and sourcing potential investment opportunities.”

Bernie Rudnick, Angel investor and advisor, CapGenic Advisors, LLC


Sign up for our daily newsletter


Venture capital investment in medical devices takes a nosedive in third quarter

November 29, 2012 10:35 am by | 0 Comments

Venture capital investment in medical devices pretty much fell off the cliff in the third quarter.

The PricewaterhouseCoopers MoneyTree Report found that medical device companies received a combined $434 million from 65 deals in the third quarter, which marks a 37 percent drop in dollar amount and a 27 percent decline in the number of deals from the second quarter.

It’s hard to believe that just one quarter ago, the medical device industry ranked second in terms of venture investment into all industries; in the third quarter, it fell to sixth place. In fact, the third-quarter investment marks the lowest amount that the device industry pulled in since 2004.

While the medical device industry sank to the bottom, overall, the life sciences sector showed signs of improvement, driven by a big influx in capital in the biotech industry, which saw a 64 percent increase from the same quarter a year ago.

Advertisement

The life sciences group saw a total investment of $1.7 billion in the third quarter through 181 deals, which represented a 16 percent increase in the amount of dollars invested from the previous quarter, although the number of deals declined 2 percent from the second quarter of 2012.

However, investment in life sciences companies in the third quarter continues a downward trajectory given that the dollar amount invested and the number of deals fell 12 percent and 8 percent respectively from the third quarter of 2011.

“The 16 percent gain for the life sciences sector reversed a four-quarter decline,” said Tracy T. Lefteroff, global managing partner of the venture capital practice at PwC U.S., in a news release. “Yet, the sector won’t outpace 2011 unless it gets a boost during the final quarter. Regulatory uncertainty, capital intensity and investment time horizons remain challenging issues for would-be investors in the sector.”

In the third quarter, venture capitalists invested a total of $6.5 billion, representing 890 deals, a decline of 10 percent in dollars invested and 12 percent in the number of deals compared with the third quarter of 2011, when VCs invested $7.3 billion in 992 deals.

Here are some additional details from the report concerning life sciences companies in the third quarter:

  • Thirty two got first-time funding totaling $170 million, a 30 percent drop in dollars invested from the third quarter of 2011, but no change in deal number
  • First-time deals averaged $5.3 million, down from $7.5 million in the third quarter of 2011
  • The top five metro areas for life sciences investing are San Francisco/Bay Area ($366 million) , Boston ($344 million), San Diego ($183 million), Chicago ($106 million) and Philadelphia ($99 million)

[Photo Credit: Declining dollar from Big Stock Photo]

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Arundhati Parmar

By Arundhati Parmar

Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.
More posts by Author

0 comments